Accéder au contenu
Merck
  • Role of transient receptor potential vanilloid 1 in regulating erythropoietin-induced activation of endothelial nitric oxide synthase.

Role of transient receptor potential vanilloid 1 in regulating erythropoietin-induced activation of endothelial nitric oxide synthase.

Acta physiologica (Oxford, England) (2016-05-28)
Y-B Yu, K-H Su, Y R Kou, B-C Guo, K-I Lee, J Wei, T-S Lee
RÉSUMÉ

Erythropoietin (EPO), the key hormone involved in erythropoiesis, beneficially affects endothelial cells (ECs), but the detailed mechanisms are yet to be completely understood. In this study, we investigated the role of transient receptor potential vanilloid type 1 (TRPV1), a ligand-gated non-selective calcium (Ca In ECs, EPO time dependently increased intracellular levels of calcium; this increase was abrogated by the Ca These findings indicate the EPO-induced Ca

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Capsazepine, ≥98% (HPLC), solid
Sigma-Aldrich
MISSION® esiRNA, targeting human ARHGAP4